The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Subcutaneous Immunotherapy Market Research Report 2025

Global Subcutaneous Immunotherapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1718123

No of Pages : 71

Synopsis
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
The global Subcutaneous Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Subcutaneous Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Subcutaneous Immunotherapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Subcutaneous Immunotherapy in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Subcutaneous Immunotherapy include Anergis, HAL Allergy Group, Merck, Allergy Therapeutics, ALK-Abello, Stallergenes Greer and Laboratorios LETI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Immunotherapy.
Report Scope
The Subcutaneous Immunotherapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
Segment by Type
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Subcutaneous Immunotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Subcutaneous Immunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Asthma
1.2.3 Allergic Rhinitis
1.2.4 Venom Allergy
1.2.5 Food Allergy
1.3 Market by Application
1.3.1 Global Subcutaneous Immunotherapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Subcutaneous Immunotherapy Market Perspective (2019-2030)
2.2 Subcutaneous Immunotherapy Growth Trends by Region
2.2.1 Global Subcutaneous Immunotherapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Subcutaneous Immunotherapy Historic Market Size by Region (2019-2024)
2.2.3 Subcutaneous Immunotherapy Forecasted Market Size by Region (2025-2030)
2.3 Subcutaneous Immunotherapy Market Dynamics
2.3.1 Subcutaneous Immunotherapy Industry Trends
2.3.2 Subcutaneous Immunotherapy Market Drivers
2.3.3 Subcutaneous Immunotherapy Market Challenges
2.3.4 Subcutaneous Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Subcutaneous Immunotherapy Players by Revenue
3.1.1 Global Top Subcutaneous Immunotherapy Players by Revenue (2019-2024)
3.1.2 Global Subcutaneous Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Subcutaneous Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Subcutaneous Immunotherapy Revenue
3.4 Global Subcutaneous Immunotherapy Market Concentration Ratio
3.4.1 Global Subcutaneous Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Immunotherapy Revenue in 2023
3.5 Subcutaneous Immunotherapy Key Players Head office and Area Served
3.6 Key Players Subcutaneous Immunotherapy Product Solution and Service
3.7 Date of Enter into Subcutaneous Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Immunotherapy Breakdown Data by Type
4.1 Global Subcutaneous Immunotherapy Historic Market Size by Type (2019-2024)
4.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Type (2025-2030)
5 Subcutaneous Immunotherapy Breakdown Data by Application
5.1 Global Subcutaneous Immunotherapy Historic Market Size by Application (2019-2024)
5.2 Global Subcutaneous Immunotherapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Subcutaneous Immunotherapy Market Size (2019-2030)
6.2 North America Subcutaneous Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Subcutaneous Immunotherapy Market Size by Country (2019-2024)
6.4 North America Subcutaneous Immunotherapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Subcutaneous Immunotherapy Market Size (2019-2030)
7.2 Europe Subcutaneous Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Subcutaneous Immunotherapy Market Size by Country (2019-2024)
7.4 Europe Subcutaneous Immunotherapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Immunotherapy Market Size (2019-2030)
8.2 Asia-Pacific Subcutaneous Immunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Subcutaneous Immunotherapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Subcutaneous Immunotherapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Subcutaneous Immunotherapy Market Size (2019-2030)
9.2 Latin America Subcutaneous Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Subcutaneous Immunotherapy Market Size by Country (2019-2024)
9.4 Latin America Subcutaneous Immunotherapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Immunotherapy Market Size (2019-2030)
10.2 Middle East & Africa Subcutaneous Immunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Subcutaneous Immunotherapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Subcutaneous Immunotherapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anergis
11.1.1 Anergis Company Detail
11.1.2 Anergis Business Overview
11.1.3 Anergis Subcutaneous Immunotherapy Introduction
11.1.4 Anergis Revenue in Subcutaneous Immunotherapy Business (2019-2024)
11.1.5 Anergis Recent Development
11.2 HAL Allergy Group
11.2.1 HAL Allergy Group Company Detail
11.2.2 HAL Allergy Group Business Overview
11.2.3 HAL Allergy Group Subcutaneous Immunotherapy Introduction
11.2.4 HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2019-2024)
11.2.5 HAL Allergy Group Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Subcutaneous Immunotherapy Introduction
11.3.4 Merck Revenue in Subcutaneous Immunotherapy Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Allergy Therapeutics
11.4.1 Allergy Therapeutics Company Detail
11.4.2 Allergy Therapeutics Business Overview
11.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Introduction
11.4.4 Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2019-2024)
11.4.5 Allergy Therapeutics Recent Development
11.5 ALK-Abello
11.5.1 ALK-Abello Company Detail
11.5.2 ALK-Abello Business Overview
11.5.3 ALK-Abello Subcutaneous Immunotherapy Introduction
11.5.4 ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2019-2024)
11.5.5 ALK-Abello Recent Development
11.6 Stallergenes Greer
11.6.1 Stallergenes Greer Company Detail
11.6.2 Stallergenes Greer Business Overview
11.6.3 Stallergenes Greer Subcutaneous Immunotherapy Introduction
11.6.4 Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2019-2024)
11.6.5 Stallergenes Greer Recent Development
11.7 Laboratorios LETI
11.7.1 Laboratorios LETI Company Detail
11.7.2 Laboratorios LETI Business Overview
11.7.3 Laboratorios LETI Subcutaneous Immunotherapy Introduction
11.7.4 Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2019-2024)
11.7.5 Laboratorios LETI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Subcutaneous Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Asthma
Table 3. Key Players of Allergic Rhinitis
Table 4. Key Players of Venom Allergy
Table 5. Key Players of Food Allergy
Table 6. Global Subcutaneous Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Subcutaneous Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Subcutaneous Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Subcutaneous Immunotherapy Market Share by Region (2019-2024)
Table 10. Global Subcutaneous Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Subcutaneous Immunotherapy Market Share by Region (2025-2030)
Table 12. Subcutaneous Immunotherapy Market Trends
Table 13. Subcutaneous Immunotherapy Market Drivers
Table 14. Subcutaneous Immunotherapy Market Challenges
Table 15. Subcutaneous Immunotherapy Market Restraints
Table 16. Global Subcutaneous Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Subcutaneous Immunotherapy Market Share by Players (2019-2024)
Table 18. Global Top Subcutaneous Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunotherapy as of 2023)
Table 19. Ranking of Global Top Subcutaneous Immunotherapy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Subcutaneous Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Subcutaneous Immunotherapy Product Solution and Service
Table 23. Date of Enter into Subcutaneous Immunotherapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Subcutaneous Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Subcutaneous Immunotherapy Revenue Market Share by Type (2019-2024)
Table 27. Global Subcutaneous Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Subcutaneous Immunotherapy Revenue Market Share by Type (2025-2030)
Table 29. Global Subcutaneous Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Subcutaneous Immunotherapy Revenue Market Share by Application (2019-2024)
Table 31. Global Subcutaneous Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Subcutaneous Immunotherapy Revenue Market Share by Application (2025-2030)
Table 33. North America Subcutaneous Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Subcutaneous Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Subcutaneous Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Subcutaneous Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Subcutaneous Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Subcutaneous Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Subcutaneous Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Subcutaneous Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Subcutaneous Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Subcutaneous Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Subcutaneous Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Subcutaneous Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Subcutaneous Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Subcutaneous Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Subcutaneous Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Anergis Company Detail
Table 49. Anergis Business Overview
Table 50. Anergis Subcutaneous Immunotherapy Product
Table 51. Anergis Revenue in Subcutaneous Immunotherapy Business (2019-2024) & (US$ Million)
Table 52. Anergis Recent Development
Table 53. HAL Allergy Group Company Detail
Table 54. HAL Allergy Group Business Overview
Table 55. HAL Allergy Group Subcutaneous Immunotherapy Product
Table 56. HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2019-2024) & (US$ Million)
Table 57. HAL Allergy Group Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Subcutaneous Immunotherapy Product
Table 61. Merck Revenue in Subcutaneous Immunotherapy Business (2019-2024) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Allergy Therapeutics Company Detail
Table 64. Allergy Therapeutics Business Overview
Table 65. Allergy Therapeutics Subcutaneous Immunotherapy Product
Table 66. Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2019-2024) & (US$ Million)
Table 67. Allergy Therapeutics Recent Development
Table 68. ALK-Abello Company Detail
Table 69. ALK-Abello Business Overview
Table 70. ALK-Abello Subcutaneous Immunotherapy Product
Table 71. ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2019-2024) & (US$ Million)
Table 72. ALK-Abello Recent Development
Table 73. Stallergenes Greer Company Detail
Table 74. Stallergenes Greer Business Overview
Table 75. Stallergenes Greer Subcutaneous Immunotherapy Product
Table 76. Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2019-2024) & (US$ Million)
Table 77. Stallergenes Greer Recent Development
Table 78. Laboratorios LETI Company Detail
Table 79. Laboratorios LETI Business Overview
Table 80. Laboratorios LETI Subcutaneous Immunotherapy Product
Table 81. Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2019-2024) & (US$ Million)
Table 82. Laboratorios LETI Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Subcutaneous Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Subcutaneous Immunotherapy Market Share by Type: 2023 VS 2030
Figure 3. Asthma Features
Figure 4. Allergic Rhinitis Features
Figure 5. Venom Allergy Features
Figure 6. Food Allergy Features
Figure 7. Global Subcutaneous Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Subcutaneous Immunotherapy Market Share by Application: 2023 VS 2030
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Subcutaneous Immunotherapy Report Years Considered
Figure 13. Global Subcutaneous Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Subcutaneous Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Subcutaneous Immunotherapy Market Share by Region: 2023 VS 2030
Figure 16. Global Subcutaneous Immunotherapy Market Share by Players in 2023
Figure 17. Global Top Subcutaneous Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunotherapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Subcutaneous Immunotherapy Revenue in 2023
Figure 19. North America Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Subcutaneous Immunotherapy Market Share by Country (2019-2030)
Figure 21. United States Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Subcutaneous Immunotherapy Market Share by Country (2019-2030)
Figure 25. Germany Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Subcutaneous Immunotherapy Market Share by Region (2019-2030)
Figure 33. China Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Subcutaneous Immunotherapy Market Share by Country (2019-2030)
Figure 41. Mexico Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Subcutaneous Immunotherapy Market Share by Country (2019-2030)
Figure 45. Turkey Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Subcutaneous Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Anergis Revenue Growth Rate in Subcutaneous Immunotherapy Business (2019-2024)
Figure 48. HAL Allergy Group Revenue Growth Rate in Subcutaneous Immunotherapy Business (2019-2024)
Figure 49. Merck Revenue Growth Rate in Subcutaneous Immunotherapy Business (2019-2024)
Figure 50. Allergy Therapeutics Revenue Growth Rate in Subcutaneous Immunotherapy Business (2019-2024)
Figure 51. ALK-Abello Revenue Growth Rate in Subcutaneous Immunotherapy Business (2019-2024)
Figure 52. Stallergenes Greer Revenue Growth Rate in Subcutaneous Immunotherapy Business (2019-2024)
Figure 53. Laboratorios LETI Revenue Growth Rate in Subcutaneous Immunotherapy Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’